141 related articles for article (PubMed ID: 12387014)
21. Mechanisms of exocytosis in insulin-secreting B-cells and glucagon-secreting A-cells.
Barg S
Pharmacol Toxicol; 2003 Jan; 92(1):3-13. PubMed ID: 12710591
[TBL] [Abstract][Full Text] [Related]
22. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
Laube H; Fussgänger RD; Schröder KE; Pfeiffer EF
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
[No Abstract] [Full Text] [Related]
23. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
Zhang CL; Katoh M; Shibasaki T; Minami K; Sunaga Y; Takahashi H; Yokoi N; Iwasaki M; Miki T; Seino S
Science; 2009 Jul; 325(5940):607-10. PubMed ID: 19644119
[TBL] [Abstract][Full Text] [Related]
24. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
[TBL] [Abstract][Full Text] [Related]
25. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
Poltorak VV; Gladkikh AI
Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
[No Abstract] [Full Text] [Related]
26. Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli.
Zhao L; Li Z; Kullin M; Borg LA; Karlsson FA
J Endocrinol; 2005 May; 185(2):291-9. PubMed ID: 15845921
[TBL] [Abstract][Full Text] [Related]
27. A red-shifted photochromic sulfonylurea for the remote control of pancreatic beta cell function.
Broichhagen J; Frank JA; Johnston NR; Mitchell RK; Šmid K; Marchetti P; Bugliani M; Rutter GA; Trauner D; Hodson DJ
Chem Commun (Camb); 2015 Apr; 51(27):6018-21. PubMed ID: 25744824
[TBL] [Abstract][Full Text] [Related]
28. [Repaglinide (NN-623)].
Matsuda M; Kaku K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():555-8. PubMed ID: 12387050
[No Abstract] [Full Text] [Related]
29. GLUT2 and glucokinase expression is coordinately regulated by sulfonylurea.
Porzio O; Marlier LN; Federici M; Hribal ML; Magnaterra R; Lauro D; Fusco A; Sesti G; Borboni P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):155-61. PubMed ID: 10459863
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Schwanstecher M; Mnner K; Panten U
Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
[TBL] [Abstract][Full Text] [Related]
31. ATP-sensitive K+ channels: a link between B-cell metabolism and insulin secretion.
Ashcroft FM; Rorsman P
Biochem Soc Trans; 1990 Feb; 18(1):109-11. PubMed ID: 2185070
[No Abstract] [Full Text] [Related]
32. Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets.
Hatakeyama H; Kishimoto T; Nemoto T; Kasai H; Takahashi N
J Physiol; 2006 Jan; 570(Pt 2):271-82. PubMed ID: 16284079
[TBL] [Abstract][Full Text] [Related]
33. Adenosine triphosphate levels of mammalian pancreatic B cells after stimulation with glucose and hypoglycemic sulfonylureas.
Hellman B; Idahl LA; Danielsson A
Diabetes; 1969 Aug; 18(8):509-16. PubMed ID: 4897289
[No Abstract] [Full Text] [Related]
34. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
Anello M; Gilon P; Henquin JC
Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
[TBL] [Abstract][Full Text] [Related]
35. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
[No Abstract] [Full Text] [Related]
36. A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
Sugawara K; Honda K; Reien Y; Yokoi N; Seki C; Takahashi H; Minami K; Mori I; Matsumoto A; Nakaya H; Seino S
PLoS One; 2016; 11(10):e0164785. PubMed ID: 27764176
[TBL] [Abstract][Full Text] [Related]
37. [The functional activity of the ATP-dependent K+ channels of normal pancreatic beta cells and in pathology].
Babichev VN
Usp Fiziol Nauk; 1999; 30(2):74-9. PubMed ID: 10420477
[TBL] [Abstract][Full Text] [Related]
38. Burst busters: uncovering a new mechanism in pancreatic beta-cells.
Keizer J
Biophys J; 1995 Jun; 68(6):2216-7. PubMed ID: 7647228
[No Abstract] [Full Text] [Related]
39. [A rapid- and short-acting insulinotropic agent KAD-1229].
Komatsu H; Ohnota H; Koizumi T; Satoh F
Nihon Rinsho; 1997 Nov; 55 Suppl():171-9. PubMed ID: 9434463
[No Abstract] [Full Text] [Related]
40. Some events at the islet cell plasma membrane that may be associated with exocytotic insulin release.
Lazarus NR; Davis B
Symp Soc Exp Biol; 1979; 33():299-321. PubMed ID: 392793
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
